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Abstract
We report the microbiological characterization of four New Delhi metallo-b-lactamase-1 (blaNDM-1)-producing
Enterobacteriaceae isolated in Rio de Janeiro, Brazil. blaNDM-1 was located on a conjugative plasmid and was associated
with Klebsiella pneumoniae carbapenemase-2 (blaKPC-2) or aminoglycoside-resistance methylase (armA), a 16S rRNA
methylase not previously reported in Brazil, in two distinct strains of Enterobacter cloacae. Our results suggested that the
introduction of blaNDM-1 in Brazil has been accompanied by rapid spread, since our isolates showed no genetic relationship.
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Introduction
Antimicrobial resistance is a growing global challenge to
human health. The New Delhi metallo-b-lactamase (NDM),
an acquired class B carbapenemase, has gained public
attention due to its rapid worldwide dissemination. blaNDM-1
was first identified in Klebsiella pneumoniae andEscherichia
coli from India and Pakistan in 2008 (1,2). Subsequent
studies reported NDM-1 from hospitals located in other
Indian cities, as well as from drinking water and seepage
water in New Delhi (3). To date, NDM-1-producing isolates
have been reported in more than 50 countries (1,4). While
many of the patients carrying NDM-1-producing strains had
a history of hospitalization in India, Pakistan or Bangladesh,
others had simply travelled to this region, whichmay indicate
community acquisition of NDM-producing bacteria by
ingestion of contaminated water and/or food. In Brazil, the
first report of NDM-1 occurred in July 2013 in a Providencia
rettgeri strain isolated from Rio Grande do Sul (5). In this
study, we characterized four Enterobacteriaceae clinical
isolates that were NDM-1 producing and were recovered at
different hospitals in Rio de Janeiro, Brazil.
Material and Methods
Four carbapenem-resistant Enterobacteriaceae strains
were isolated from various sites from four different patients
admitted at four different hospitals located in two cities in the
state of Rio de Janeiro between September and October
2013. These isolates were identified asP. rettgeri andEnter-
obacter cloacae (ECL) (n=3) using a Vitek1 2 Compact
automated system (bioMe´rieux Clinical Diagnostics,
France). These isolates were resistant to carbapenems,
with a minimum inhibitory concentration (MIC)>2 mg/mL for
imipenem or meropenem and an MIC >1 mg/mL for erta-
penem. Because of that, they were screened for carbape-
nemase production by testing commercially available disks
containing carbapenems with and without EDTA (0.1 M),
cloxacillin (75 mg/mL) or phenylboronic acid (40 mg/mL), as
recommended by the National Health Surveillance Agency
(ANVISA) technical guidelines (6).
Since the diameter-zone difference between the carba-
penem/EDTA and carbapenem disks was >5 mm, these
strains were screened as possible metallo-b-lactamase
(MBL) producers and referred to the Laborato´rio Especial
de Microbiologia Clı´nica, UNIFESP, Sa˜o Paulo, SP, Brazil
for further molecular characterization. The Enterobacteria-
ceae strains were re-identified at the species level by matrix-
assisted laser desorption ionization time-of-flight (MALDI-ToF)
mass spectroscopy (Bruker Daltonics, Germany), using the
Biotyper 3.0 software (Bruker Daltonics, Germany), and
16S rRNA DNA sequencing.
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The antimicrobial susceptibility profile was performed
and interpreted by the Clinical and Laboratory Standards
Institute (CLSI) broth microdilution guidelines (7), except
for polymyxin B, for which the European Committee on
Antimicrobial Susceptibility Testing (EUCAST) (8) break-
points were applied. The MBL phenotype was investigated
by the MBL imipenem/imipenem-inhibitor (IP/IPI) E-test
method (AB Biodisk, Sweden). Detection of the following
encoding genes, blaNDM, blaKPC, blaGES, blaSPM, blaGIM,
blaSIM, blaVIM, blaCTX-M, blaSHV, blaTEM, blaOXA-48, and 16S
rRNA methylase genes, rmtA, rmtB, rmtC, rmtD, rmtG,
armA and npmA, was carried out by PCR followed by DNA
sequencing (ABI sequencer, Applied Biosystems, USA).
Clonal relatedness among ECL isolates was evaluated
by pulsed field gel electrophoresis (PFGE) using the SpeI
restriction endonuclease (New England BioLabs, USA). The
band patterns were analyzed by visual inspection, applying
the criteria established by Tenover et al. (9). Conjugation
and transformation experiments were performed using E.
coli J53 (LacZ– Nalr Rifr) and E. coli DH5a, respectively, as
recipient strains. Transconjugants were selected on
MacConkey agar, using imipenem (0.5 mg/mL) and azide
(150 mg/mL). Plasmids and whole genome DNA were
extracted from the strains and from E. coli J53 by the
Kieser method (10) and with a QIAamp DNA Mini Kit
(Qiagen, Germany), respectively, and analyzed using a
0.8% agarose gel. A replicon-based PCR typing of plasmid
incompatibility groups (Inc/rep) was performed using pre-
viously published protocols (11,12) with 5 multiplex and
6 single reactions recognizing the FIA, FIB, FIC, HI1, HI2,
I1-Iy, L/M, N, P, W, T, A/C, K, B/O, X, Y, F, FIIA, and Q
replicons.
Results
The results of this study are summarized in Table 1.
The initial identification of bacterial species was con-
firmed, as well as the MBL phenotype, by the E-test. All















Site of isolation Catheter – Urine Blood – Ascitic fluid –
PFGE pattern – – A B – C –
MIC (mg/mL)*
IMI 32 8 16 16 32 8 0.06
IMI/AC 32 8 16 16 16 8 –
Mero 32 8 32 12 64 4 0.13
MERO/AC 32 8 32 16 16 32 –
Erta 256 64 128 256 128 16 0.01
Erta/AC 128 32 256 256 128 128 –
Poly B .128 ,0.125 0.25 0.25 ,0.25 ,0.25 ,0.25
CEF 256 128 512 .512 256 64 0.06
Cipro .256 0.016 .32 64 0.016 0.032 0.008
Levo .256 ,0.25 64 16 ,0.25 ,0.25 0.125
CAZ .512 .512 .512 .512 .512 .512 0.125
Tige 0.5 0.06 0.25 1 0.06 0.25 0.25
CRO 512 512 .512 .512 .512 512 –
CFL .512 .512 .512 .512 .512 .512 –
Genta 0.25 2 .128 64 1 1 0.125
Amica 4 2 .256 4 2 4 ,2
CTX .512 .512 .512 .512 .512 .512 0.06
MBL E-test + + + + + + –















NDM-1: New Delhi metallo-b-lactamase-1; PFGE: pulsed field gel electrophoresis; IMI: imipenem; AC: clavulanic acid; Mero:
meropenem; Erta: ertapenem; Poly B: polymixyn B; CEF: cefepime; Cipro: ciprofloxacin; Levo: levofloxacin; CAZ: ceftazidime; Tige:
tigecycline; CRO: ceftriaxone; CFL: cephalothin; Genta: gentamicin; Amica: amikacin; CTX: cefotaxime; MBL: metallo-b-lactamase.
*Minimum inhibitory concentrations (MICs) were determined by agar dilution [Clinical and Laboratory Standards Institute (CLSI) 2013].
** The E135 sample tested negative for all plasmid incompatibility groups.
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isolates were resistant to broad-spectrum cephalosporins,
ertapenem, imipenem, and meropenem. The ECL isolates
were susceptible to polymyxin B, but the P. rettgeri isolate
(#E132) was resistant to this agent, as expected. The
presence of blaNDM-1 and blaTEM-1 was confirmed in all
isolates. All ECL isolates carried blaCTX-M-15 and possessed
different PFGE patterns. Co-occurrence of blaNDM-1 with
armA or with blaKPC-2 genes was detected in two distinct
ECL strains, E134 and E133, respectively. The transference
of blaNDM-1 to a recipient strain was achieved for strains
E132 and E134, suggesting that this gene was probably
located on a ,230 kb conjugative plasmid that belonged
to the Inc/rep P type. The transference of blaNDM-1 by
conjugation failed for the remaining isolates. Hybridization
revealed that the blaKPC-2 gene was located on the
chromosome of the E134 isolate. This finding explained
why repetitive attempts to transfer blaKPC-2 by conjugation
have failed. Electroporation experiments were unsuccessful.
Transconjugant strains showed the same elevation of
carbapenem MICs as exhibited by donor strains.
Discussion
Carbapenems are the most frequently used antibiotics
for the treatment of multidrug-resistant Enterobacteriaceae
infections. Few therapeutic options are available for treat-
ment of carbapenemase-producing Enterobacteriaceae,
especially for Providencia spp. isolates that are intrinsically
resistant to polymyxins.
Although blaNDM-1 has been described in Brazil recently
(5), we observed that reports by clinical laboratories of
isolates possessing this enzyme became more frequent
after the implementation of the ANVISA technical stan-
dards. This technical document recommends MBL screen-
ing of all carbapenem-resistant Enterobacteriaceae, using
carbapenem plus carbapenem/EDTA.
Previous studies detected the association of NDM-1
with other carbapenemases and methylase genes (13-16).
In Brazil, Bueno and colleagues (16) recently described the
coproduction of the rmtG methylase in K. pneumoniae
isolates that carried blaKPC-2 and blaCTX-M-15. To the best
of our knowledge, this study is the first to describe the
association of blaNDM-1 and blaKPC-2 in Brazilian isolates, as
well as the association of blaNDM-1 with armA, a 16S rRNA
methylase gene. Moreover, this is the first report of armA
among Brazilian clinical isolates.
The emergence of blaNDM-1 in association with other
resistance genes demonstrates the rapid evolution of
bacteria and the ability to acquire and keep different
resistance genes. This fact is worrisome because the
antimicrobial options available for treatment of these
infections are decreasing. The distinct patterns observed
among ECL clinical isolates suggest that blaNDM-1 had
spread silently in the hospitals.
Acknowledgments
The authors would like to thank Marcus Vinı´cius
Gaspari and Ana Carolina R. Silva (Laborato´rio Especial
de Microbiologia Clı´nica, UNIFESP) for their technical
assistance with the PFGE and MALDI-ToF assays. M.G.
Quiles is a PhD student financially supported by CAPES.
A.C. Gales and A.C.C. Pignatari are researchers from
CNPq.
References
1. Nordmann P, Poirel L, Walsh TR, Livermore DM. The
emerging NDM carbapenemases. Trends Microbiol 2011;
19: 588-595, doi: 10.1016/j.tim.2011.09.005.
2. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F,
Balakrishnan R, et al. Emergence of a new antibiotic
resistance mechanism in India, Pakistan, and the UK: a
molecular, biological, and epidemiological study. Lancet Infect
Dis 2010; 10: 597-602, doi: 10.1016/S1473-3099(10)70143-2.
3. Walsh TR, Weeks J, Livermore DM, Toleman MA.
Dissemination of NDM-1 positive bacteria in the New Delhi
environment and its implications for human health: an
environmental point prevalence study. Lancet Infect Dis
2011; 11: 355-362, doi: 10.1016/S1473-3099(11)70059-7.
4. Nordmann P, Dortet L, Poirel L. Carbapenem resistance in
Enterobacteriaceae: here is the storm! Trends Mol Med
2012; 18: 263-272.
5. Carvalho-Assef AP, Pereira PS, Albano RM, Beriao GC,
Chagas TP, Timm LN, et al. Isolation of NDM-producing
Providencia rettgeri in Brazil. J Antimicrob Chemother 2013;
68: 2956-2957, doi: 10.1093/jac/dkt298.
6. Ageˆncia Nacional de Vigilaˆncia Sanita´ria. ANVISA. Medidas
de prevenc¸a˜o e controle de infecc¸o˜es por Enterobacte´rias
multiresistentes. Nota Te´cnica N. 1/2013. http://portal.anvisa.
gov.br. Accessed January 20, 2014.
7. Clinical and Laboratory Standards Institute. Performance
standards for antimicrobial susceptibility testing. 23rd
Informational Supplement. Wayne: Clinical and Laboratory
Standards Institute (M100-S23); 2014.
8. European Committee on Antimicrobial Susceptibility
Testing. EUCAST. Breakpoint tables for interpretation of
MICs and zone diameters. http://www.eucast.org/clinical_
breakpoints/. Accessed January 20, 2014.
9. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray
BE, Persing DH, et al. Interpreting chromosomal DNA
restriction patterns produced by pulsed-field gel electrophor-
esis: criteria for bacterial strain typing. J Clin Microbiol 1995;
33: 2233-2239.
10. Kieser T. Factors affecting the isolation of CCC DNA from
Streptomyces lividans and Escherichia coli. Plasmid 1984;
12: 19-36, doi: 10.1016/0147-619X(84)90063-5.
11. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall
EJ. Identification of plasmids by PCR-based replicon typing.
J Microbiol Methods 2005; 63: 219-228, doi: 10.1016/
j.mimet.2005.03.018.
176 M.G. Quiles et al.
Braz J Med Biol Res 48(2) 2015 www.bjournal.com.br
12. Gotz A, Pukall R, Smit E, Tietze E, Prager R, Tschape H,
et al. Detection and characterization of broad-host-range
plasmids in environmental bacteria by PCR. Appl Environ
Microbiol 1996; 62: 2621-2628.
13. ShomaS, KamruzzamanM, Ginn AN, Iredell JR, Partridge SR.
Characterization of multidrug-resistant Klebsiella pneumoniae
from Australia carrying blaNDM-1. Diagn Microbiol Infect Dis
2014; 78: 93-97, doi: 10.1016/j.diagmicrobio.2013.08.001.
14. Islam MA, Huq M, Nabi A, Talukdar PK, Ahmed D, Talukder
KA, et al. Occurrence and characterization of multidrug-
resistant New Delhi metallo-beta-lactamase-1-producing
bacteria isolated between 2003 and 2010 in Bangladesh.
J Med Microbiol 2013; 62: 62-68, doi: 10.1099/jmm.0.
048066-0.
15. Kumarasamy K, Kalyanasundaram A. Emergence of
Klebsiella pneumoniae isolate co-producing NDM-1 with
KPC-2 from India. J Antimicrob Chemother 2012; 67: 243-
244, doi: 10.1093/jac/dkr431.
16. Bueno MF, Francisco GR, O’Hara JA, de Oliveira Garcia D,
Doi Y. Coproduction of 16S rRNA methyltransferase RmtD
or RmtG with KPC-2 and CTX-M group extended-spectrum
beta-lactamases in Klebsiella pneumoniae. Antimicrob
Agents Chemother 2013; 57: 2397-2400, doi: 10.1128/
AAC.02108-12.
NDM-1 associated with KPC-2 in Brazil 177
www.bjournal.com.br Braz J Med Biol Res 48(2) 2015
